These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33917160)

  • 1. Evaluation of Safety and Efficacy of an Inactivated Marker Vaccine against
    Petrini S; Martucciello A; Grandoni F; De Matteis G; Cappelli G; Giammarioli M; Scoccia E; Grassi C; Righi C; Fusco G; Galiero G; Pela M; De Mia GM; De Carlo E
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33917160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an Immunization Protocol Using Bovine Alphaherpesvirus 1 gE-Deleted Marker Vaccines against Bubaline Alphaherpesvirus 1 in Water Buffaloes.
    Martucciello A; Balestrieri A; Righi C; Cappelli G; Scoccia E; Grassi C; Brandi S; Rossi E; Galiero G; Gioia D; Fusco G; Feliziani F; De Carlo E; Petrini S
    Vaccines (Basel); 2023 Apr; 11(5):. PubMed ID: 37242994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
    Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
    Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.
    Romera SA; Puntel M; Quattrocchi V; Del Médico Zajac P; Zamorano P; Blanco Viera J; Carrillo C; Chowdhury S; Borca MV; Sadir AM
    BMC Vet Res; 2014 Jan; 10():8. PubMed ID: 24401205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Passive Immunity Induced by Immunisation Using Two Inactivated gE-deleted Marker Vaccines against Infectious Bovine Rhinotracheitis (IBR) in Calves.
    Petrini S; Righi C; Iscaro C; Viola G; Gobbi P; Scoccia E; Rossi E; Pellegrini C; De Mia GM
    Vaccines (Basel); 2020 Jan; 8(1):. PubMed ID: 31947899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine herpesvirus type 1 marker vaccine induces cross-protection against bubaline herpesvirus type 1 in water buffalo.
    Montagnaro S; De Martinis C; Iovane V; Ciarcia R; Damiano S; Nizza S; De Martino L; Iovane G; Pagnini U
    Prev Vet Med; 2014 Sep; 116(1-2):56-62. PubMed ID: 24985155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Hematological Profiles and Monocyte Subpopulations in Water Buffalo Calves after Immunization with Two Different IBR Marker Vaccines and Subsequent Infection with
    Grandoni F; Hussen J; Signorelli F; Napolitano F; Scatà MC; De Donato I; Cappelli G; Galiero G; Grassi C; De Carlo E; Petrini S; De Matteis G; Martucciello A
    Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766082
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of antibodies against Bubaline herpesvirus (BuHV-1) among Mediterranean water buffalo (Bubalus bubalis) with implications in buffalo trade.
    Caruso C; Prato R; Ingravalle F; Vecchio D; Sciarra A; Ternavasio M; Ceccarelli L; Martucciello A; Galiero G; De Carlo E; Masoero L
    Vet Q; 2016 Dec; 36(4):184-188. PubMed ID: 27334411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
    Kalthoff D; König P; Trapp S; Beer M
    Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field Evaluation of Commercial Vaccines against Infectious Bovine Rhinotracheitis (Ibr) Virus Using Different Immunization Protocols.
    De Brun L; Leites M; Furtado A; Campos F; Roehe P; Puentes R
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33924141
    [No Abstract]   [Full Text] [Related]  

  • 12. Endogenous and viral microRNAs in nasal secretions of water buffaloes (Bubalus bubalis) after Bubaline alphaherpesvirus 1 (BuHV-1) challenge infection.
    Lecchi C; Ceciliani F; Petrini S; Cappelli G; Grassi C; Balestrieri A; Galiero G; DeCarlo E; Salvi G; Panzeri F; Gini C; Cafiso A; Agazzi A; Martucciello A
    Vet Res; 2023 Jun; 54(1):44. PubMed ID: 37277883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant bovine herpesvirus 5 defective in thymidine kinase and glycoprotein E is immunogenic for calves and confers protection upon homologous challenge and BoHV-1 challenge.
    Anziliero D; Santos CM; Brum MC; Weiblen R; Chowdhury SI; Flores EF
    Vet Microbiol; 2011 Dec; 154(1-2):14-22. PubMed ID: 22019288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses in bovines to recombinant glycoprotein D of bovine herpesvirus type 5 as vaccine antigen.
    Araujo IL; Dummer LA; Rodrigues PRC; Dos Santos AG; Fischer G; Cunha RC; Leite FPL
    Vaccine; 2018 Nov; 36(50):7708-7714. PubMed ID: 30381153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should the domestic buffalo (Bubalus bubalis) be considered in the epidemiology of Bovine Herpesvirus 1 infection?
    Scicluna MT; Caprioli A; Saralli G; Manna G; Barone A; Cersini A; Cardeti G; Condoleo RU; Autorino GL
    Vet Microbiol; 2010 Jun; 143(1):81-8. PubMed ID: 20206452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction, characterization and immunogenicity of a glycoprotein E negative bovine herpesvirus-1.1 Egyptian strain "Abu-Hammad".
    El-Kholy AA; Rady DI; Abdou ER; Elseafy MM; Abdelrahman KA; Soliman H
    J Virol Methods; 2013 Dec; 194(1-2):74-81. PubMed ID: 23962750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing antibodies to bovine and bubaline alphaherpesviruses in water buffaloes (Bubalus bubalis).
    Scheffer CM; Varela APM; Teixeira TF; Schmidt C; Cibulski SP; Dos Santos HF; Duarte PM; Campos FS; Franco AC; Roehe PM
    Braz J Microbiol; 2023 Jun; 54(2):1231-1237. PubMed ID: 36897516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term study (2005-2010) on the vaccination with BoHV-1 glycoprotein E-deleted marker vaccine in selected two dairy herds in Turkey.
    Alkan F; Bilge-Dagalp S; Karapınar Z; Timurkan MO; Coskun N; Burgu I
    Trop Anim Health Prod; 2018 Feb; 50(2):353-363. PubMed ID: 29071668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of an inactivated vaccine for intravaginal application against bovine alphaherpesvirus type 5 (BoHV-5).
    Peter CM; da Silva Barcelos L; Ferreira MRA; Waller SB; Frühauf MI; Botton NY; Conceição FR; de Lima M; de Oliveira Hübner S; Barichello JM; Fischer G
    Mol Immunol; 2023 Mar; 155():69-78. PubMed ID: 36731192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Different Infectious Bovine Rhinotracheitis Marker Vaccines in Calves.
    Petrini S; Martucciello A; Righi C; Cappelli G; Torresi C; Grassi C; Scoccia E; Costantino G; Casciari C; Sabato R; Giammarioli M; De Carlo E; Feliziani F
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 36016092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.